VivoSim Labs (VIVS) Accumulated Depreciation (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Accumulated Depreciation of $1.7 million for Q1 2026, up 14.0% year-over-year from $1.5 million in Q1 2025, and up 14.0% quarter-over-quarter from $1.5 million in Q1 2025.
VivoSim Labs (VIVS) Accumulated Depreciation (2011 - 2026) Analysis & Trends
VivoSim Labs' Accumulated Depreciation history runs 16 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 14.0% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 14.0% YoY), while the FY2026 annual figure was $1.7 million, up 14.0% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $1.7 million, up from $1.5 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $1.7 million in Q1 2026, with the low at $1.1 million in Q1 2022.
- The 5-year median for Accumulated Depreciation is $1.3 million (2023), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation declined 1.41% in 2024, then rose 20.91% in 2025.
- VivoSim Labs' Accumulated Depreciation stood at $1.1 million in 2022, then increased by 19.14% to $1.3 million in 2023, then dropped by 1.41% to $1.3 million in 2024, then climbed by 20.91% to $1.5 million in 2025, then increased by 14.0% to $1.7 million in 2026.
- Business Quant data shows VIVS's Accumulated Depreciation at $1.7 million in Q1 2026, $1.5 million in Q1 2025, and $1.3 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Mar 31, 2022 | 1.07 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Mar 31, 2020 | 415,000.00 |
| Mar 31, 2019 | 4.58 Mn |
| Mar 31, 2018 | 4.07 Mn |
| Mar 31, 2017 | 2.92 Mn |
| Mar 31, 2016 | 1.81 Mn |
| Mar 31, 2015 | 1.00 Mn |
| Mar 31, 2014 | 574,000.00 |
| Mar 31, 2013 | 270,000.00 |
| Dec 31, 2012 | 192,000.00 |
| Dec 31, 2011 | 148,000.00 |